Literature DB >> 11466410

Inflammatory genes are upregulated in expanded ataxin-3-expressing cell lines and spinocerebellar ataxia type 3 brains.

B O Evert1, I R Vogt, C Kindermann, L Ozimek, R A de Vos, E R Brunt, I Schmitt, T Klockgether, U Wüllner.   

Abstract

Spinocerebellar ataxia type 3 (SCA3) is a polyglutamine disorder caused by a CAG repeat expansion in the coding region of a gene encoding ataxin-3. To study putative alterations of gene expression induced by expanded ataxin-3, we performed PCR-based cDNA subtractive hybridization in a cell culture model of SCA3. In rat mesencephalic CSM14.1 cells stably expressing expanded ataxin-3, we found a significant upregulation of mRNAs encoding the endopeptidase matrix metalloproteinase 2 (MMP-2), the transmembrane protein amyloid precursor protein, the interleukin-1 receptor-related Fos-inducible transcript, and the cytokine stromal cell-derived factor 1alpha (SDF1alpha). Immunohistochemical studies of the corresponding or associated proteins in human SCA3 brain tissue confirmed these findings, showing increased expression of MMP-2 and amyloid beta-protein (Abeta) in pontine neurons containing nuclear inclusions. In addition, extracellular Abeta-immunoreactive deposits were detected in human SCA3 pons. Furthermore, pontine neurons of SCA3 brains strongly expressed the antiinflammatory interleukin-1 receptor antagonist, the proinflammatory cytokine interleukin-1beta, and the proinflammatory chemokine SDF1. Finally, increased numbers of reactive astrocytes and activated microglial cells were found in SCA3 pons. These results suggest that inflammatory processes are involved in the pathogenesis of SCA3.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11466410      PMCID: PMC6762679     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  60 in total

1.  Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders.

Authors:  K Gijbels; S Masure; H Carton; G Opdenakker
Journal:  J Neuroimmunol       Date:  1992-11       Impact factor: 3.478

2.  Expression of stromal cell-derived factor-1 and CXCR4 chemokine receptor mRNAs in cultured rat glial and neuronal cells.

Authors:  Y Ohtani; M Minami; N Kawaguchi; A Nishiyori; J Yamamoto; S Takami; M Satoh
Journal:  Neurosci Lett       Date:  1998-06-19       Impact factor: 3.046

3.  Cell death and apoptosis regulating proteins in Parkinson's disease--a cautionary note.

Authors:  U Wüllner; J Kornhuber; M Weller; J B Schulz; P A Löschmann; P Riederer; T Klockgether
Journal:  Acta Neuropathol       Date:  1999-04       Impact factor: 17.088

4.  Characterization of type II intracellular IL-1 receptor antagonist (IL-1ra3): a depot IL-1ra.

Authors:  M Muzio; N Polentarutti; F Facchetti; G Peri; A Doni; M Sironi; P Transidico; M Salmona; M Introna; A Mantovani
Journal:  Eur J Immunol       Date:  1999-03       Impact factor: 5.532

5.  Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70.

Authors:  J M Warrick; H Y Chan; G L Gray-Board; Y Chai; H L Paulson; N M Bonini
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

6.  Proteolysis of A beta peptide from Alzheimer disease brain by gelatinase A.

Authors:  A E Roher; T C Kasunic; A S Woods; R J Cotter; M J Ball; R Fridman
Journal:  Biochem Biophys Res Commun       Date:  1994-12-30       Impact factor: 3.575

7.  Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

Authors:  F Saudou; S Finkbeiner; D Devys; M E Greenberg
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

8.  Low affinity binding of interleukin-1 beta and intracellular signaling via NF-kappa B identify Fit-1 as a distant member of the interleukin-1 receptor family.

Authors:  A Reikerstorfer; H Holz; H G Stunnenberg; M Busslinger
Journal:  J Biol Chem       Date:  1995-07-28       Impact factor: 5.157

9.  Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact.

Authors:  B D Shivers; C Hilbich; G Multhaup; M Salbaum; K Beyreuther; P H Seeburg
Journal:  EMBO J       Date:  1988-05       Impact factor: 11.598

10.  Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation.

Authors:  M K Perez; H L Paulson; S J Pendse; S J Saionz; N M Bonini; R N Pittman
Journal:  J Cell Biol       Date:  1998-12-14       Impact factor: 10.539

View more
  37 in total

Review 1.  Toward understanding Machado-Joseph disease.

Authors:  Maria do Carmo Costa; Henry L Paulson
Journal:  Prog Neurobiol       Date:  2011-11-23       Impact factor: 11.685

2.  Promoter Variation and Expression Levels of Inflammatory Genes IL1A, IL1B, IL6 and TNF in Blood of Spinocerebellar Ataxia Type 3 (SCA3) Patients.

Authors:  Mafalda Raposo; Conceição Bettencourt; Amanda Ramos; Nadiya Kazachkova; João Vasconcelos; Teresa Kay; Jácome Bruges-Armas; Manuela Lima
Journal:  Neuromolecular Med       Date:  2016-05-31       Impact factor: 3.843

3.  An α2-Na/K ATPase/α-adducin complex in astrocytes triggers non-cell autonomous neurodegeneration.

Authors:  Gilbert Gallardo; Jessica Barowski; John Ravits; Teepu Siddique; Jerry B Lingrel; Janice Robertson; Hanno Steen; Azad Bonni
Journal:  Nat Neurosci       Date:  2014-10-26       Impact factor: 24.884

4.  Cytokines in Machado Joseph Disease/Spinocerebellar Ataxia 3.

Authors:  Gerson da Silva Carvalho; Jonas Alex Morales Saute; Clarissa Branco Haas; Vitor Rocco Torrez; Andressa Wigner Brochier; Gabriele Nunes Souza; Gabriel Vasata Furtado; Tailise Gheno; Aline Russo; Thais Lampert Monte; Artur Schumacher-Schuh; Rui D'Avila; Karina Carvalho Donis; Raphael Machado Castilhos; Diogo Onofre Souza; Maria Luiza Saraiva-Pereira; Vanessa Leotti Torman; Suzi Camey; Luis Valmor Portela; Laura Bannach Jardim
Journal:  Cerebellum       Date:  2016-08       Impact factor: 3.847

5.  Overexpression of Cystathionine γ-Lyase Suppresses Detrimental Effects of Spinocerebellar Ataxia Type 3.

Authors:  Pauline M Snijder; Madina Baratashvili; Nicola A Grzeschik; Henri G D Leuvenink; Lucas Kuijpers; Sippie Huitema; Onno Schaap; Ben N G Giepmans; Jeroen Kuipers; Jan Lj Miljkovic; Aleksandra Mitrovic; Eelke M Bos; Csaba Szabó; Harm H Kampinga; Pascale F Dijkers; Eelke M Bos; Csaba Szabó; Harm H Kampinga; Pascale F Dijkers; Wilfred F A den Dunnen; Milos R Filipovic; Harry van Goor; Ody C M Sibon
Journal:  Mol Med       Date:  2015-10-13       Impact factor: 6.354

6.  Synergistic Toxicity of Polyglutamine-Expanded TATA-Binding Protein in Glia and Neuronal Cells: Therapeutic Implications for Spinocerebellar Ataxia 17.

Authors:  Yang Yang; Su Yang; Jifeng Guo; Yiting Cui; Beisha Tang; Xiao-Jiang Li; Shihua Li
Journal:  J Neurosci       Date:  2017-08-18       Impact factor: 6.167

7.  Antisense oligonucleotide therapy rescues aggresome formation in a novel spinocerebellar ataxia type 3 human embryonic stem cell line.

Authors:  Lauren R Moore; Laura Keller; David D Bushart; Rodrigo G Delatorre; Duojia Li; Hayley S McLoughlin; Maria do Carmo Costa; Vikram G Shakkottai; Gary D Smith; Henry L Paulson
Journal:  Stem Cell Res       Date:  2019-07-16       Impact factor: 2.020

8.  Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice.

Authors:  Hayley S McLoughlin; Lauren R Moore; Ravi Chopra; Robert Komlo; Megan McKenzie; Kate G Blumenstein; Hien Zhao; Holly B Kordasiewicz; Vikram G Shakkottai; Henry L Paulson
Journal:  Ann Neurol       Date:  2018-08-06       Impact factor: 10.422

9.  Interleukin-1 alpha polymorphism has influence on late-onset sporadic Parkinson's disease in Taiwan.

Authors:  Y R Wu; C M Chen; J C Hwang; S T Chen; I H Feng; H C Hsu; C N Liu; Y T Liu; Y Y Lai; H J Huang; G J Lee-Chen
Journal:  J Neural Transm (Vienna)       Date:  2007-04-26       Impact factor: 3.575

10.  Implantation of olfactory ensheathing cells promotes neuroplasticity in murine models of stroke.

Authors:  Woei-Cherng Shyu; Demeral David Liu; Shinn-Zong Lin; Wen-Wen Li; Ching-Yuan Su; Ying-Chen Chang; Hsiao-Jung Wang; Hsing-Won Wang; Chang-Hai Tsai; Hung Li
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.